Prev Arrow Stocks

Chemours Company (The) ($CC) Stock Forecast: Down 5.1% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Chemours Company (The)?

Chemours Inc. (NYSE: CC) is currently trading at $18.60, with a recent 0.85% drop in its stock price. The company has experienced a 2.23% decrease in the past month and a significant 39.17% decline over the past year.

Why is Chemours Company (The) going down?

CC stock is down 5.1% on Dec 19, 2024 18:00

  • The bearish movement in Chemours Inc.'s stock (CC) today could be attributed to:
  • Investor concerns about the company's long-term performance, as evidenced by the significant decline in the stock price over the past year.
  • Market participants possibly reacting to the recent 0.85% drop in the stock price, leading to a further downward pressure on the shares.
  • The focus on the company's price-to-earnings ratio may have raised questions about the company's valuation, prompting some investors to sell off their positions.

CC Price Chart

CC Technical Analysis

CC News

Price Over Earnings Overview: Chemours - Chemours ( NYSE:CC )

In the current session, Chemours Inc. CC is trading at $18.60, after a 0.85% drop. Over the past month, the stock fell by 2.23%, and in the past year, by 39.17%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio.

https://www.benzinga.com/insights/news/24/12/42535366/price-over-earnings-overview-chemours

0 News Article Image Price Over Earnings Overview: Chemours - Chemours  ( NYSE:CC )

Chemours Company (The) Price History

21.05.2024 - CC Stock was down 5.1%

  • The decrease in the short percent of float for Chemours suggests a decline in bearish sentiment among traders.
  • A lower volume of shares sold short could alleviate selling pressure that might have been driving the stock price down.
  • The market's response to these developments likely influenced the bearish movement in Chemours' stock today.

08.10.2024 - CC Stock was down 5.3%

  • Despite surpassing Q3 earnings and revenue estimates, CC's stock faced a significant bearish movement.
  • The market's reaction may stem from concerns that future growth prospects may not meet the elevated expectations set by the positive Q3 results.
  • Investors could be engaging in profit-taking following a period of robust performance, contributing to the stock's downward trend.
  • External factors or unrelated market conditions may have also played a role in influencing the bearish movement.

12.08.2024 - CC Stock was up 5.7%

  • CC showcased its dedication to sustainability and innovation with the development of a low GWP retrofit approach for vehicles.
  • Anticipated substantial carbon dioxide equivalent savings by 2025 with their Opteon portfolio are expected to increase investor confidence.
  • This positive development is believed to have positively impacted CC's stock performance today.

21.10.2024 - CC Stock was up 5.3%

  • CC is a leading company in the technology sector, specializing in semiconductor manufacturing. The overall market showed positive momentum today, with many tech stocks experiencing gains.
  • CC stock surged as investors reacted positively to Valvoline's impressive Q4 earnings and revenue results.
  • The strong performance of Valvoline likely boosted investor confidence in the overall market, leading to increased buying activity in CC.
  • The better-than-expected earnings report from Valvoline may have signaled to investors that the technology sector, including companies like CC, is performing well and has strong growth potential.

12.11.2024 - CC Stock was down 7.5%

  • A chemical company, CC, experienced a bearish movement in the stock market.
  • Assessment
  • CC's collaboration with PCC Group may result in rising production costs.
  • Concerns may arise among investors regarding the chlorine supply agreement's effect on CC's profit margins.
  • The market's negative reaction suggests anticipation of future challenges for CC in the competitive chemical sector.

10.11.2024 - CC Stock was down 5.0%

  • The bearish movement in CC today could be attributed to profit-taking by investors after a recent 8.8% increase since the last earnings report.
  • Investors might be cautious about the future outlook of CC, leading to selling pressure despite positive earnings estimates.
  • Market sentiment could be influenced by external factors impacting the chemical industry, prompting a bearish trend in CC's stock price.

19.11.2024 - CC Stock was down 5.1%

  • The bearish movement in Chemours Inc.'s stock (CC) today could be attributed to:
  • Investor concerns about the company's long-term performance, as evidenced by the significant decline in the stock price over the past year.
  • Market participants possibly reacting to the recent 0.85% drop in the stock price, leading to a further downward pressure on the shares.
  • The focus on the company's price-to-earnings ratio may have raised questions about the company's valuation, prompting some investors to sell off their positions.

13.05.2024 - CC Stock was up 5.9%

  • Chemours released its 2023 Sustainability Report, emphasizing its dedication to environmental and social responsibility.
  • Investor confidence in the company's sustainability efforts likely increased following the approval of its science-based emissions reduction targets by the Science Based Target initiative.
  • The market positively reacted to Chemours' advancements in achieving its 2030 Corporate Responsibility Commitment goals, reflecting a growing investor focus on firms with robust ESG initiatives.
  • The uptick in CC's stock can be linked to the company's proactive stance on sustainability and ethical business practices, appealing to investors interested in socially responsible investment opportunities.

14.05.2024 - CC Stock was up 5.5%

  • The stock surged 5.5% with higher than average trading volume.
  • Chemours expanded its board by appointing Livingston “Tony” Satterthwaite as a new independent director.
  • The appointment of a new director may have instilled confidence in investors, leading to the bullish movement.
  • The market seems optimistic about the potential for business growth under the leadership of the new board member.

11.06.2024 - CC Stock was up 7.1%

  • Upgrade of Chemours stock to ''Buy'' by UBS, signaling a positive outlook.
  • UBS had previously noted undue negativity on the stock but now anticipates it to outperform.
  • This upgrade is likely a contributing factor to the positive movement in Chemours' stock price today.

07.07.2024 - CC Stock was down 5.1%

  • Chemours (CC) experienced a significant earnings shortfall in Q2, primarily due to lower selling prices.
  • Insights gleaned from the period ending June 30, 2024, earnings call may have highlighted challenges impacting investor confidence.
  • The unsatisfactory Q2 earnings, missing both earnings and revenue projections, likely prompted a decline in CC's stock value.
  • Investor confidence in the company's future performance may be eroded by the unexpected earnings results and their potential repercussions on profitability.

02.07.2024 - CC Stock was down 13.9%

  • Following a significant miss in Q2 earnings estimates, Chemours (CC) faced a strong downward trend in the market.
  • The substantial negative surprise in earnings (-42.42%) likely influenced the pessimistic sentiments surrounding CC's stock.
  • The activity in the options market suggests that investors may have been privy to potential challenges or had existing concerns regarding Chemours' earnings performance, contributing to the bearish movement.
  • Despite the favorable prospects for chemical stocks overall, Chemours' disappointing financial results in Q2 eclipsed the growth potential within the industry, leading to a decline in the company's stock valuation.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.